• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR

PARADIGM BIOPHARMACEUTICALS LIMITED..

1.69% ! 29.0¢
Market Cap $112.9M  !

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug... Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.More

Corporate Spotlight

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight arrow Created with Sketch.

PAR - close to a cure for osteoarthritis?

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAR
The Ghosh Study - PART 1
00:18 0 108
00:18 Last post  Mozzarc Comments Created with Sketch.  0  Views Created with Sketch.  108 
PAR
Where are we on a deal?
22 23 24
14/06/25 1.4K 464K
14/06/25 Last post  Mozzarc Comments Created with Sketch.  1.4K  Views Created with Sketch.  464K 
PAR
compounding chemist
14/06/25 32 13K
14/06/25 Last post  bandos2000 Comments Created with Sketch.  32  Views Created with Sketch.  13K 
PAR
PAR and the former bus driver, a comparison?
11/06/25 13 4.2K
11/06/25 Last post  poolboy Comments Created with Sketch.  13  Views Created with Sketch.  4.2K 
PAR
outcomes of the meeting on 29 may
2
06/06/25 103 35K
06/06/25 Last post  Figaraw Comments Created with Sketch.  103  Views Created with Sketch.  35K 
PAR 06/06/25 32 11K
06/06/25 Last post  Weazel Comments Created with Sketch.  32  Views Created with Sketch.  11K 
PAR
Paradigm activates first Aus site for osteoarthritis drug trials
03/06/25 1 685
03/06/25 Last post  asx11 Comments Created with Sketch.  1  Views Created with Sketch.  685 
PAR
OARSI 2025
02/06/25 53 21K
02/06/25 Last post  the buck Comments Created with Sketch.  53  Views Created with Sketch.  21K 

See All Discussions arrow Created with Sketch.

Timeline

Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
03 Jun 08:41
 
Results of Meeting
29 May 17:10
 
PAR Receives US Ethics Approval for Phase 3
15 May 08:24
 
Notice of General Meeting/Proxy Form
29 Apr 16:57
 
March 2025 Quarterly Activities Report & Appendix 4C
29 Apr 13:51
 
Paradigm to present at NWR Healthcare Conference
18 Mar 15:02
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $112.9M
Open High Low Value Volume
29.5¢ 31.0¢ 28.5¢ $431.5K 1.469M

Buyers (Bids)

No. Vol. Price($)
3 21578 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 9000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.